Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Diana Dawson"'
Publikováno v:
Annals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology. 127(4)
Background Patients with cystic fibrosis (CF) often have a history of antibiotic adverse drug reactions (ADRs) that pose a barrier to receiving recommended first-line treatment. Targeted antibiotic allergy evaluations are increasingly recognized as a
Autor:
Jennifer J. Tian, Mary Ellen Kleinhenz, Serena Ranucci, Colin Valet, Emma Lefrançais, Michelle Yu, Peter M. Haggie, Kristin M. Wang, Mark R. Looney, Nicholas Kwaan, Fadi T. Khasawneh, Zhe Liu, Guadalupe Ortiz-Muñoz, Diana Dawson, Alan S. Verkman, Beñat Mallavia
Publikováno v:
The Journal of clinical investigation, vol 130, iss 4
J Clin Invest
Journal of Clinical Investigation
Journal of Clinical Investigation, American Society for Clinical Investigation, 2020, 130 (4), pp.2041-2053. ⟨10.1172/JCI129635⟩
J Clin Invest
Journal of Clinical Investigation
Journal of Clinical Investigation, American Society for Clinical Investigation, 2020, 130 (4), pp.2041-2053. ⟨10.1172/JCI129635⟩
Cystic fibrosis (CF) lung disease is characterized by an inflammatory response that can lead to terminal respiratory failure. The cystic fibrosis transmembrane conductance regulator (CFTR) is mutated in CF, and we hypothesized that dysfunctional CFTR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33c23a51ad3f74f770f77a2c31a11111
https://escholarship.org/uc/item/0dx571vd
https://escholarship.org/uc/item/0dx571vd
Autor:
Michael Lee, Karen M. Anstey, Diana Dawson, Jonathan M. Budzik, Michelle Yu, Mary Ellen Kleinhenz, Vicki Jue, Iris M. Otani
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 8:3631-3633.e1
Autor:
Claire D. Brindis, Thida Ong, Diana Dawson, Mary Ellen Kleinhenz, Dennis W. Nielson, Nancy Lewis, Megumi J. Okumura, Martha Richards
Publikováno v:
Okumura, MJ; Ong, T; Dawson, D; Nielson, D; Lewis, N; Richards, M; et al.(2014). Improving transition from paediatric to adult cystic fibrosis care: Programme implementation and evaluation. BMJ Quality and Safety, 23(SUPPL1). doi: 10.1136/bmjqs-2013-002364. UCSF: Retrieved from: http://www.escholarship.org/uc/item/6zv2w1xk
BMJ quality & safety, vol 23 Suppl 1, iss SUPPL1
BMJ quality & safety, vol 23 Suppl 1, iss SUPPL1
Background: The paradigm of cystic fibrosis (CF) care has changed as effective therapies extend the lives of patients well into adulthood. Preparing for and maintaining high quality CF care into the adult healthcare setting is critical for prolonged